Concepedia

Regina Berkovich

RB

13

Publications

285

Citations

10

H-Index

2011

Active since

Affiliations

University of Southern California(Current)

Sanofi (United States)

Urology San Antonio

University of British Columbia

First Pavlov State Medical University of St. Petersburg

Regina Berkovich is an author at University of Southern California specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2011–2021

13

Publications

13

Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study

Tjalf Ziemssen, Ann Bass, Regina Berkovich et al. · CNS Drugs · 2020 · 55 citations · Full text

Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223

Brian Steingo, Yaser Al Malik, Ann Bass et al. · Journal of Neurology · 2020 · 52 citations · Full text

Effects of dimethyl fumarate on lymphocyte subsets

Regina Berkovich, Leslie P. Weiner · Multiple Sclerosis and Related Disorders · 2015 · 45 citations

, , +7

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies

Raed Alroughani, Aaron Boster, Ann Bass et al. · Multiple Sclerosis Journal · 2019 · 20 citations · Full text

Adrenocorticotropic hormone <i>versus</i> methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial

Regina Berkovich, Rohit Bakshi, Lilyana Amezcua et al. · Therapeutic Advances in Neurological Disorders · 2016 · 17 citations · Full text

Rows per page

1–5 of 13